Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus

Vaccine

Volumn 25, Issue 5, 2007, Pages 814-824

  Gaudreau, Marie Claude ^a   Lacasse, Pierre ^b   Talbot, Brian G ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b SHERBROOKE RESEARCH AND DEVELOPMENT CENTRE   (Canada)

Author keywords

Arthritis; DNA vaccine; Septicemia; Staphylococcus aureus; Th1 and Th2

Indexed keywords

DNA VACCINE; FIBRONECTIN BINDING PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G2A ANTIBODY; PCI PROTEIN; PCLFA PROTEIN; PCLFASRTD13 PROTEIN; PD13 PROTEIN; POLYPROTEIN; PSRT PROTEIN; RECOMBINANT VACCINE; SORTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTHRITIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INTERFERON PRODUCTION; MOUSE; MULTIGENE FAMILY; NEWMAN STRAIN; NONHUMAN; PATHOGENESIS; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; REACTIVE ARTHRITIS; SEPTICEMIA; STAPHYLOCOCCUS INFECTION; TH1 CELL; TH2 CELL;

ADHESINS, BACTERIAL; AMINOACYLTRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTERIAL PROTEINS; COAGULASE; CYSTEINE ENDOPEPTIDASES; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; VACCINATION; VACCINES, DNA;

EID: 33845194899     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.09.043     Document Type: Article

References (50)

1. Kluytmans J., van Belkum A., and Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10 (1997) 505-520
2. Padmanabhan R.A., and Fraser T.G. The emergence of methicillin-resistant Staphylococcus aureus in the community. Cleve Clin J Med 72 (2005) 235-241
3. Chambers H.F. Community-associated MRSA-resistance and virulence converge. N Engl J Med 352 (2005) 1485-1487
4. Whitener C.J., Park S.Y., Browne F.A., Parent L.J., Julian K., Bozdogan B., et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis 38 (2004) 1049-1055
5. Fattom A.I., Horwith G., Fuller S., Propst M., and Naso R. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials. Vaccine 22 7 (2004) 880-887
6. Shinefield H.R. Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: is an additional vaccine needed or possible?. Vaccine 24 Suppl. 2 (2006) S2-65-9
7. Weichhart T., Horky M., Sollner J., Gangl S., Henics T., Nagy E., et al. Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro. Infect Immun 71 8 (2003) 4633-4641
8. Foster T.J., and Höök M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 40 (1994) 79-89
9. McDevitt D., Francois P., Vaudaux P., and Foster T.J. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 11 (1994) 237-248
10. Ingham K.C., Brew S., Vaz D., Sauder D.N., and McGavin M.J. Interaction of Staphylococcus aureus fibronectin-binding protein with fibronectin. J Biol Chem 279 (2004) 42945-42953
11. Wann E.R., Gurusiddappa S., and Höök M. The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J Biol Chem 275 (2000) 13863-13871
12. Schneewind O., Fowler A., and Faull K.F. Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science 268 (1995) 103-106
13. Palmqvist N., Foster T., Fitzgerald T., Josefsson E., and Tarkowski A. Fibronectin-binding proteins and fibrinogen-binding clumping factors play distinct roles in Staphylococcal arthritis and systemic inflammation. J Infect Dis 191 (2005) 791-798
14. Jonsson I.-M., Mazmanian S.K., Schneewind O., Bremell T., and Tarkowski A. The role of Staphylococcus aureus sortase A and sortase B in murine arthritis. Microb Infec 5 (2003) 775-780
15. Jonsson I.-M., Mazmanian S.K., Schneewind O., Verdrengh M., Bremell T., and Tarkowski A. On the role of Staphylococcus aureus sortase and sortase-catalysed surface protein anchoring in murine septic arthritis. J Infect Dis 185 (2002) 1417-1424
16. Mazmanian S.K., Liu G., Jensen E.R., Lenoy E., and Schneewind O. Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections. PNAS 97 (2000) 5510-5515
17. Johansson A., Flock J.-I., and Svensson O. Collagen and fibronectin binding in experimental Staphylococcal osteomyelitis. Clin Ortho Rel Res 382 (2000) 241-246
18. Josefsson E., Hartford O., O'Brien L., Patti J.M., and Foster T. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 184 (2001) 1572-1580
19. Mckenney D., et al. J Biotech 83 (2000) 37
20. Zhou H., Xiong Z.Y., Li H.P., Zheng Y.L., and Jiang Y.Q. An immunogenicity study of a newly fusion protein Cna-FnBP vaccinated against Staphylococcus aureus infections in a mice model. Vaccine 24 22 (2006) 4830-4837
21. Gresham F.I.D., Lowrance J.H., Caver T.E., Wilson B.S., Cheung A.L., and Lindberg F.P. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immun 164 (2000) 3713-3722
22. Brouillette E., Grondin G., Shkreta L., Lacasse P., and Talbot B.G. In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin-binding proteins. Microb Pathogen 35 (2003) 159-168
23. Ahmed S., Meghji S., Williams R.J., Henderson B., Brock J.H., and Nair S.P. Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria. Infect Immun 69 (2001) 2872-2877
24. von Eiff C., Peters G., and Becker K. The small colony variant (SCV) concept-the role of staphylococcal SCVs in persistent infections. J Article Injury 37 May (Suppl. 2) (2006) S26-S33
25. Deng G.-M., Nilsson I.-M., Verdrengh M., Collins L.V., and Tarkowski A. Intra-articular localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 5 (1999) 702-705
26. Nilsson I.-M., Patti J.M., Bremell T., Höök M., and Tarkowski A. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J Clin Invest 101 (1998) 2640-2649
27. Liu M.A. DNA vaccines: a review. J Intern Med 253 (2003) 402-410
28. Manoj S., Babiuk L.A., and Van Drunen Littel-van den Hurk S. Approaches for enhancing the efficacy of DNA vaccines. Crypt Rev Clin Lab Sci 41 (2004) 1-39
29. Oran A.E., and Robinson H.L. DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells. J Immunol 171 (2003) 1999-2005
30. Chattergoon M.A., Saulino V., Shames J.P., Stein J., Montaner L.J., and Weiner D.B. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine 22 (2004) 1744-1750
31. Sasaki S., Takeshita F., Xin K.Q., Ishii N., and Okuda K. Adjuvant formulations and delivery systems for DNA vaccines. Methods 31 (2003) 243-254
32. Daly L.M., Johnson P.A., Donnelly G., Nicolson C., Robertson J., and Mills K.H. Innate IL-10 promotes the induction of Th2 responses with plasmid DNA expressing HIV gp120. Vaccine 23 (2005) 963-974
33. Perrie Y., McNeil S., and Vangala A. Liposome-mediated DNA immunization via the subcutaneous route. J Drug Target 11 (2003) 555-563
34. Planelles L., Thomas M.C., Alonso C., and Lopez M.C. DNA immunization with Tryponosoma cruzi HSP70 fused to the KMP11 protein elicits cytotoxic and humoral immune responses against the antigen and leads to protection. Infect Immun 69 (2001) 6558-6563
35. Shkreta L., Talbot B.G., and Lacasse P. Optimization of DNA vaccination immune responses in dairy cows: effect of injection site and the targeting efficacy of antigen-bCTLA-4 complex. Vaccine 21 (2003) 2372-2382
36. Bennett A.M., Perkins S.D., and Holley J.L. DNA vaccination protects against botulinum neurotoxin type F. Vaccine 21 (2003) 3110-3117
37. Senna J.P.M., Roth D.M., Oliveira J.S., Machabo D.C., and Santos D.S. Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach. Vaccine 21 (2003) 2661-2666
38. Ohwada A., Sekiya M., Hanaki H., Arai K.K., Nagaoka I., Hori S., et al. DNA vaccination by a mecA sequence evokes an antimicrobial immune response against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemo 44 (1999) 767-774
39. Tian X., Cai H., and Zhu Y.X. Protection of mice with a divalent tuberculosis DNA vaccine encoding antigens Ag85B and MPT64. Acta Biochim Biophys Sin (Shanghai) 36 (2004) 269-276
40. Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2 (1996) 893-898
41. Shkreta L., Talbot B.G., Diarra M.S., and Lacasse P. Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows. Vaccine 23 (2004) 114-126
42. Brouillette E., Lacasse P., Shkreta L., Bélanger J., Grondin G., Diarra M.S., et al. DNA immunization against the clumping factor A (Clf A) of Staphylococcus aureus. Vaccine 20 (2002) 2348-2357
43. Kerro-Dego O.P., Prysliak T., Potter A.A., and Perez-Casal J. DNA-protein immunization against the GapB and GapC proteins of a mastitis isolate of Staphylococcus aureus. Vet Immunol Immunopathol 113 1-2 (2006) 125-138
44. Guo J.H., Jia R., Fan M.W., Bian Z., Chen Z., and Peng B. Construction and immunogenic characterization of a fusion anti-caries DNA vaccine against Pac and glucosyltransferase 1 of Streptococcus mutans. J Dent Res 83 (2004) 266-270
45. Mannering S.I., Morris J.S., Jensen K.P., Purcell A.W., Honeyman M.C., van Endert P.M., et al. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J Immun Methods 283 (2003) 173-183
46. Abdelnour A., Bremell T., Holmdahl R., and Tarkowski A. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin 1-producing staphylococci. Eur J Immunol 24 (1994) 1161-1166
47. Patti J.M., Bremell T., Krajewska-Pietrasik D., Abdelnour A., Tarkowski A., Rydén C., et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 62 (1994) 152-161
48. Liu Z.-Q., Deng G.-M., Foster S., and Tarkowski A. Staphylococcal peptidoglycans induce arthritis. Arthrit Res 3 (2001) 375-380
49. Deng G.-M., and Tarkowski A. The features of arthritis induced by CpG motifs in bacterial DNA. Arthritis Rheum 43 (2000) 356-364
50. Zhao Y.X., Nilsson I.M., and Tarkowski A. The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology 93 1 (1998) 80-85